Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation. We report on innovative drug introductions and promising pipeline candidates from Big Pharma and smaller players, as well as relevant clinical trial trends. The publication also covers promising technological developments relevant to the biotech, biopharma and pharma industries, including advances in artificial intelligence, genomic/proteomic sequencing and microscopy. Other areas of focus include orphan drugs, drug advances for oncology, neurological disease and infectious disease including vaccines and other therapies for COVID-19. Our content includes staff-written articles as well as contributed content from experts. The publication serves the pharmaceutical, biopharmaceutical and biotechnology industries, contract research organizations, government laboratories, universities, hospitals, medical centers and others within the life science marketplace. Our readers include informatics specialists, staff scientists, research scientists, corporate and lab management and scientists conducting and leading research within the field. Drug Discovery and Development is a MassDevice-affiliated pharmaceutical industry news website, owned by Cleveland-based WTWH Media. We stand by journalistic ethics to provide the most up-to-date, accurate and fairly reported information for our readers. Sign up for our newsletter: https://www.drugdiscoverytrends.com/enews-signup/ For advertising inquiries, visit our Media Guide: https://marketing.wtwhmedia.com/2023-pharma-media-guide